News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
355,841 Results
Type
Article (14326)
Company Profile (123)
Press Release (341392)
Section
Business (112548)
Career Advice (448)
Deals (18631)
Drug Delivery (22)
Drug Development (31251)
Employer Resources (48)
FDA (8783)
Job Trends (7696)
News (172655)
Policy (12383)
Tag
Academia (1322)
Africa (312)
Alliances (34513)
Alzheimer's disease (414)
Approvals (8764)
Arizona (88)
Artificial intelligence (72)
Asia (23465)
Australia (4083)
Bankruptcy (128)
Best Places to Work (6363)
Biotechnology (92)
C2C Services and Suppliers (54735)
California (949)
Canada (502)
Cancer (237)
Career advice (398)
CAR-T (30)
Cell therapy (74)
China (76)
Clinical research (23549)
Collaboration (109)
Colorado (54)
Connecticut (39)
COVID-19 (1104)
Cystic fibrosis (39)
Data (149)
Diagnostics (4610)
Earnings (37357)
Employer resources (41)
Europe (47722)
Events (49555)
Executive appointments (81)
FDA (8914)
Florida (150)
Funding (91)
Gene therapy (51)
Georgia (41)
GLP-1 (166)
Government (1224)
Healthcare (9831)
Hotbed/Location (244513)
Idaho (33)
Illinois (128)
Indiana (70)
Infectious disease (1116)
Inflammatory bowel disease (46)
Interviews (48)
IPO (7919)
Job creations (1431)
Job search strategy (358)
Kansas (74)
Layoffs (105)
Legal (2501)
Lung cancer (42)
Manufacturing (44)
Maryland (227)
Massachusetts (675)
Medical device (11232)
Medtech (11237)
Mergers & acquisitions (10711)
Metabolic disorders (59)
Michigan (113)
Minnesota (139)
Neuroscience (456)
New Hampshire (50)
New Jersey (316)
New York (275)
NextGen Class of 2024 (3526)
Non-profit (1509)
North Carolina (330)
Northern California (418)
Obesity (30)
Ohio (54)
Opinion (63)
Patents (50)
Pennsylvania (252)
People (31962)
Phase I (8655)
Phase II (10682)
Phase III (6912)
Pipeline (52)
Podcasts (34)
Postmarket research (502)
Preclinical (3941)
Press Release (66)
Radiopharmaceuticals (146)
Rare diseases (61)
Real estate (3340)
Regulatory (8962)
Research institute (1269)
Resumes & cover letters (65)
South America (498)
Southern California (400)
Startups (2500)
Texas (132)
United States (4506)
Utah (30)
Vaccines (197)
Washington State (168)
Date
Today (42)
Last 7 days (328)
Last 30 days (1236)
Last 365 days (20051)
2024 (14146)
2023 (22161)
2022 (30901)
2021 (32606)
2020 (30661)
2019 (25837)
2018 (19471)
2017 (18897)
2016 (17777)
2015 (20570)
2014 (15186)
2013 (12746)
2012 (13788)
2011 (14071)
2010 (12830)
355,841 Results for "alveo technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Alveo’s Portable, Rapid Molecular Diagnostic Platform Proves Unshakable in Rigorous Ruggedness Tests
Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, announced the results of rigorous testing that demonstrate the ruggedness of its portable molecular testing platform.
June 18, 2024
·
3 min read
Business
Alveo Technologies Partners with NYtor to Develop Rapid Molecular Test for the Dominant Swine Flu Strains
Alveo Technologies, Inc. announced a partnership with NYtor B.V, an innovative assay developer, to create a rapid, accurate, pen-side test that will detect the dominant swine flu strains, including H1N1, H1N2 and H3N2.
April 23, 2024
·
3 min read
Biotech Bay
Alveo Technologies Announces Major Distribution Expansion Across EMEA
Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, announced 19 new distributor partnerships across Europe, Africa, and the Middle East.
December 13, 2023
·
3 min read
Biotech Bay
Alveo Technologies Is Developing Groundbreaking Avian Influenza Molecular Test for Poultry in Partnership with x-OvO, Royal GD, and Pharmsure
Alveo Technologies, Inc. announced it is working with experts and leaders in the poultry industry to launch a rapid, accurate, in-the-field multiplex panel to test for all relevant strains of avian influenza, initially focusing on Group A, H5, H7, and H9.
January 9, 2024
·
5 min read
Business
Alveo Technologies and Corteva Agriscience Collaborate to Advance Molecular Crop Disease Diagnostics and Improve Crop Yields
Alveo Technologies, Inc. announced a collaboration with Corteva Agriscience to expand the offering of its novel eco-friendly molecular sensing and disease diagnostics technology to include a first-in-field agricultural disease diagnostic.
October 24, 2023
·
5 min read
News
Alveo Technologies Demonstrates its Rapid Avian Influenza Molecular Test Panel Detects Latest H5N1 Variants in Cattle and the Recent Human Infections in Colorado
July 18, 2024
·
4 min read
Biotech Bay
Alveo Technologies Announces ISO 13485:2016 Certification
Alveo Technologies, Inc. today announced its quality management system (QMS) has achieved ISO 13485:2016 certification for the design, development and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease.
March 21, 2023
·
4 min read
Biotech Bay
Flockscreen LAMP Avian Influenza Test for Poultry First Rapid Molecular Test to Accurately Detect the Presence of Virus in Both Cloacal and Oropharyngeal Samples
Alveo Technologies, Inc. announced that rigorous development and testing has demonstrated that the Flockscreen LAMP Avian Influenza Molecular Test can accurately detect the presence of virus in both cloacal and oropharyngeal samples from poultry with comparable limit of detection, sensitivity and specificity.
June 27, 2024
·
5 min read
Biotech Bay
Alveo Technologies Announces Partner Program and Portal, New Enablement Software Suite, Further Empowering Partners in Co-Development of Advanced Molecular Diagnostics
Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, launched a web-based partner portal and suite of enablement software tools to further drive innovative partnerships onto the platform to co-develop and commercialize rapid, point of need diagnostic solutions across multiple life sciences industry sectors.
July 11, 2023
·
5 min read
Business
Alveo Technologies Announces New Executive Leadership, Open Platform Strategy
Alveo Technologies, Inc. announced the appointment of three life sciences industry leaders to its senior executive team to advance the development of its novel molecular sensing and diagnostics technology and lead the company through strategic growth and commercialization of its rapid, multiplexed molecular diagnostic platform, be.well™.
November 17, 2022
·
6 min read
1 of 35,585
Next